Physician profile
Ajay Patel
NPI 1033679998
$3,656.75
in general payments reported to CMS, 2019-2025
10 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,805 · 2024: $1,671 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,840 · Travel and Lodging: $1,817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,839.53 |
| Travel and Lodging | $1,817.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,509.41 | 2023-2024 | Vanta Adaptivestim, Intellis Adaptivestim |
| Boston Scientific Corporation | $1,087.32 | 2023-2024 | |
| Stratus Medical, LLC | $386.13 | 2023-2025 | Nimbus |
| Biotronik Nro, INC. | $168.95 | 2024 | Prospera |
| Pacira Pharmaceuticals Incorporated | $133.73 | 2023-2024 | Zilretta, Exparel, Iovera |
| Curonix LLC | $122.59 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $80.36 | 2024 | Eterna |
| Stryker Corporation | $60.92 | 2024 | Optablate, Spinejack |
| Beckman Coulter, INC. | $54.84 | 2023 | Unicel Dxh 690t Coulter Cellular Analysis System |
| Spr Therapeutics, INC | $52.50 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.